Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GSK256066 in mild steroid-naive asthma
NCT00445510Phase 2Completed
- Sponsor
- GSK
- Start
- Jun 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of GSK256066 in asthma, sponsored by GSK. Started Jun 2006; status: completed.
02
Drugs
GSK256066
03
Conditions
asthma
Beyond the preview
Go deeper on NCT00445510.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00445510.